{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T08:13:11Z","timestamp":1761725591291,"version":"build-2065373602"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"AstraZeneca\uff0cChina"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04495-4","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:47:11Z","timestamp":1761659231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["C-INSIGHT: design and methodology of a nationwide registry for high-risk chronic kidney disease in China \u2013 a study protocol"],"prefix":"10.1186","volume":"26","author":[{"given":"Guihua","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyan","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangbiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaosheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianying","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianbiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guisen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijuan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jicheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingfeng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bicheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"4495_CR1","first-page":"453","volume":"38","author":"Expert Group on Kidney Clinical Quality Control Center in Shanghai","year":"2022","unstructured":"Expert Group on Kidney Clinical Quality Control Center in Shanghai. Guidelines for early screening, diagnosis, prevention and treatment of chronic kidney disease (2022 Edition). Chin J Nephrol. 2022;38:453\u201364.","journal-title":"Chin J Nephrol"},{"key":"4495_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/jamainternmed.2022.6817","volume":"183","author":"L Wang","year":"2023","unstructured":"Wang L, Xu X, Zhang M, et al. Prevalence of chronic kidney disease in china: results from the sixth China chronic disease and risk factor surveillance. JAMA Intern Med. 2023;183:298\u2013310.","journal-title":"JAMA Intern Med"},{"key":"4495_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.phrs.2017.11.003","volume":"129","author":"SE Kjeldsen","year":"2018","unstructured":"Kjeldsen SE. Hypertension and cardiovascular risk: general aspects. Pharmacol Res. 2018;129:95\u20139.","journal-title":"Pharmacol Res"},{"key":"4495_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s40265-019-1064-1","volume":"79","author":"D Pugh","year":"2019","unstructured":"Pugh D, Gallacher PJ, Dhaun N. Management of hypertension in chronic kidney disease. Drugs. 2019;79:365\u201379.","journal-title":"Drugs"},{"key":"4495_CR5","doi-asserted-by":"crossref","unstructured":"Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2011;80:17\u201328.","DOI":"10.1038\/ki.2010.483"},{"key":"4495_CR6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in china: a cross-sectional survey. Lancet. 2012;379:815\u201322.","journal-title":"Lancet"},{"key":"4495_CR7","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2023.17002","volume":"330","author":"ME Grams","year":"2023","unstructured":"Grams ME, Coresh J, Matsushita K, et al. Estimated glomerular filtration Rate, Albuminuria, and adverse outcomes: an Individual-Participant data Meta-Analysis. JAMA. 2023;330:1266\u201377.","journal-title":"JAMA"},{"key":"4495_CR8","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/ki.2010.550","volume":"79","author":"BC Astor","year":"2011","unstructured":"Astor BC, Matsushita K, Gansevoort RT, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int. 2011;79:1331\u201340.","journal-title":"Kidney Int"},{"key":"4495_CR9","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stef\u00e1nsson BV, Correa-Rotter R, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383:1436\u201346.","journal-title":"N Engl J Med"},{"key":"4495_CR10","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic V, Jardine MJ, Neal B, et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med. 2019;380:2295\u2013306.","journal-title":"N Engl J Med"},{"key":"4495_CR11","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"JT Wright Jr","year":"2015","unstructured":"Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard Blood-Pressure control. N Engl J Med. 2015;373:2103\u201316.","journal-title":"N Engl J Med"},{"key":"4495_CR12","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1681\/ASN.2017020148","volume":"28","author":"AK Cheung","year":"2017","unstructured":"Cheung AK, Rahman M, Reboussin DM, et al. Effects of intensive BP control in CKD. J Am Soc Nephrol. 2017;28:2812\u201323.","journal-title":"J Am Soc Nephrol"},{"key":"4495_CR13","first-page":"48","volume":"39","author":"Chinese Society of Nephrology","year":"2023","unstructured":"Chinese Society of Nephrology. Guidelines for hypertension management in patients with chronic kidney disease in China (2023). Chin J Nephrol. 2023;39:48\u201380.","journal-title":"Chin J Nephrol"},{"key":"4495_CR14","doi-asserted-by":"publisher","first-page":"S148","DOI":"10.1097\/01.ASN.0000070149.78399.CE","volume":"14","author":"HI Feldman","year":"2003","unstructured":"Feldman HI, Appel LJ, Chertow GM, et al. The chronic renal insufficiency cohort (CRIC) study: design and methods. J Am Soc Nephrol. 2003;14:S148\u201353.","journal-title":"J Am Soc Nephrol"},{"key":"4495_CR15","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s10157-010-0328-6","volume":"14","author":"S Enyu Imai","year":"2010","unstructured":"Enyu Imai S, Matsuo H, Makino, et al. Chronic kidney disease Japan cohort study: baseline characteristics and factors associated with causative disease and renal function. Clin Exp Nephrol. 2010;14:558\u201370.","journal-title":"Clin Exp Nephrol"},{"key":"4495_CR16","doi-asserted-by":"publisher","first-page":"e019457","DOI":"10.1136\/bmjopen-2017-019457","volume":"8","author":"S Liang","year":"2018","unstructured":"Liang S, Wang WL, Zhu FL, et al. Chinese observational prospective study of ageing population with chronic kidney disease (C-OPTION): a study protocol. BMJ Open. 2018;8:e019457.","journal-title":"BMJ Open"},{"key":"4495_CR17","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.3760\/cma.j.issn.0366-6999.20132906","volume":"127","author":"B Gao","year":"2014","unstructured":"Gao B, Zhang L, Wang H, et al. Chinese cohort study of chronic kidney disease: design and methods. Chin Med J (Engl). 2014;127:2180\u20135.","journal-title":"Chin Med J (Engl)"},{"key":"4495_CR18","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"4495_CR19","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C-Based equations to estimate GFR without race. N Engl J Med. 2021;385:1737\u201349.","journal-title":"N Engl J Med"},{"key":"4495_CR20","unstructured":"KDIGO. 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1\u2043150."},{"key":"4495_CR21","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.kint.2020.07.013","volume":"98","author":"A Levin","year":"2020","unstructured":"Levin A, Agarwal R, Herrington WG, et al. International consensus definitions of clinical trial outcomes for kidney failure: 2020. Kidney Int. 2020;98:849\u201359.","journal-title":"Kidney Int"},{"key":"4495_CR22","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.117.033502","volume":"137","author":"KA Hicks","year":"2018","unstructured":"Hicks KA, Mahaffey KW, Mehran R, et al. 2017 cardiovascular and stroke endpoint definitions for clinical trials. Circulation. 2018;137:961\u201372.","journal-title":"Circulation"},{"key":"4495_CR23","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1093\/eurheartj\/ehx209","volume":"40","author":"P Rossignol","year":"2019","unstructured":"Rossignol P, Agarwal R, Canaud B, et al. Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints. Eur Heart J. 2019;40:880\u20136.","journal-title":"Eur Heart J"},{"key":"4495_CR24","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2023.17002","volume":"330","author":"ME Grams","year":"2023","unstructured":"Writing Group for the CKD Prognosis Consortium, Grams ME, Coresh J, et al. Estimated glomerular filtration Rate, Albuminuria, and adverse outcomes: an Individual-Participant data Meta-Analysis. JAMA. 2023;330:1266\u201377.","journal-title":"JAMA"},{"key":"4495_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/ki.2010.531","volume":"80","author":"RT Gansevoort","year":"2011","unstructured":"Gansevoort RT, Matsushita K, van der Velde M, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80:93\u2013104.","journal-title":"Kidney Int"},{"key":"4495_CR26","doi-asserted-by":"publisher","first-page":"648","DOI":"10.2215\/CJN.07830520","volume":"16","author":"M Hannan","year":"2021","unstructured":"Hannan M, Ansari S, Meza N, et al. Risk factors for CKD progression: overview of findings from the CRIC study. Clin J Am Soc Nephrol. 2021;16:648\u201359.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4495_CR27","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1681\/ASN.2020050723","volume":"31","author":"M Oshima","year":"2020","unstructured":"Oshima M, Neuen BL, Li J, et al. Early change in albuminuria with Canagliflozin predicts kidney and cardiovascular outcomes: A posthoc analysis from the CREDENCE trial. J Am Soc Nephrol. 2020;31:2925\u201336.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"4495_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/j.ajkd.2019.06.009","volume":"75","author":"S Andrew","year":"2020","unstructured":"Andrew S, Levey RT, Gansevoort, et al. Change in albuminuria and GFR as end points for clinical trials in early stages of CKD: A scientific workshop sponsored by the National kidney foundation in collaboration with the US food and drug administration and European medicines agency. Am J Kidney Dis. 2020;75(1):84\u2013104.","journal-title":"Am J Kidney Dis"},{"key":"4495_CR29","doi-asserted-by":"publisher","first-page":"e2214460","DOI":"10.1001\/jamanetworkopen.2022.14460","volume":"5","author":"X Fu","year":"2022","unstructured":"Fu X, Ren H, Xie J, et al. Association of nighttime masked uncontrolled hypertension with left ventricular hypertrophy and kidney function among patients with chronic kidney disease not receiving Dialysis. JAMA Netw Open. 2022;5:e2214460.","journal-title":"JAMA Netw Open"},{"key":"4495_CR30","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1161\/HYPERTENSIONAHA.122.19902","volume":"80","author":"S Wu","year":"2023","unstructured":"Wu S, Li M, Lu J, et al. Blood pressure Levels, cardiovascular Events, and renal outcomes in chronic kidney disease without antihypertensive therapy: A nationwide Population-Based cohort study. Hypertension. 2023;80:640\u20139.","journal-title":"Hypertension"},{"key":"4495_CR31","doi-asserted-by":"crossref","unstructured":"Ying Z, Cai GY, Chen XM, et al. Prevalence, awareness, treatment, and control of hypertension in the non-dialysis chronic kidney disease patients. Chin Med J. 2013;126(12): 2276\u20132280.","DOI":"10.3760\/cma.j.issn.0366-6999.20130835"},{"key":"4495_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/jch.13761","volume":"22","author":"Q Bianlin Liu","year":"2020","unstructured":"Bianlin Liu Q, Wang Y, Wang, et al. Utilization of antihypertensive drugs among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE). J Clin Hypertens. 2020;22:57\u201364.","journal-title":"J Clin Hypertens"},{"key":"4495_CR33","doi-asserted-by":"crossref","unstructured":"Muntner P, Anderson A, Charleston J, et al. Hypertension awareness, treatment, and control in adults with CKD: results from the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis. 2010 Mar;55(3):441\u201351.","DOI":"10.1053\/j.ajkd.2009.09.014"},{"key":"4495_CR34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12325-021-02006-z","volume":"39","author":"JJ Garcia Sanchez","year":"2022","unstructured":"Garcia Sanchez JJ, Thompson J, Scott DA, et al. Treatments for chronic kidney disease: A systematic literature review of randomized controlled trials. Adv Ther. 2022;39:193\u2013220.","journal-title":"Adv Ther"},{"key":"4495_CR35","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105:S117\u2013314.","journal-title":"Kidney Int"},{"key":"4495_CR36","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.2215\/CJN.08900722","volume":"17","author":"P Vart","year":"2022","unstructured":"Vart P, Vaduganathan M, Jongs N, et al. Estimated lifetime benefit of combined RAAS and SGLT2 inhibitor therapy in patients with albuminuric CKD without diabetes. Clin J Am Soc Nephrol. 2022;17:1754\u201362.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4495_CR37","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD, et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med. 2020;383:2219\u201329.","journal-title":"N Engl J Med"},{"key":"4495_CR38","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","volume":"385","author":"B Pitt","year":"2021","unstructured":"Pitt B, Filippatos G, Agarwal R, et al. Cardiovascular events with finerenone in kidney disease and type 2 diabetes. N Engl J Med. 2021;385:2252\u201363.","journal-title":"N Engl J Med"},{"key":"4495_CR39","first-page":"424","volume":"49","author":"R Abraham","year":"2019","unstructured":"Abraham R, Schneider J, vom Brocke J. Data governance: A conceptual framework, structured review, and research agenda. Int J Inf Manage. 2019;49:424\u201338.","journal-title":"Int J Inf Manage"},{"key":"4495_CR40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12953-017-0116-2","volume":"15","author":"J Eriksson","year":"2017","unstructured":"Eriksson J, Andersson S, Appelqvist R, et al. Merging clinical chemistry biomarker data with a COPD database - building a clinical infrastructure for proteomic studies. Proteome Sci. 2017;15:8.","journal-title":"Proteome Sci"},{"key":"4495_CR41","unstructured":"Von Elm E, Altman DG, Egger M, et al. Strengthening the Report of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04495-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04495-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04495-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T01:06:36Z","timestamp":1761699996000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04495-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4495"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04495-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol (28 Nov 2023, Version 2.0) has been approved by the Ethical Review Committee of Affiliated Zhongda Hospital of Southeast University (Approval Number: 2023ZDSYLL313-P01). All participants will provide written informed consent before enrollment. The findings of the study will be published in peer-reviewed journals and will follow the STROBE reporting guideline, [\n                      \n                      ] and may be presented at national or international conferences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consents to publish are not required for this manuscript since no patient data are reported.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"599"}}